These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16854540)

  • 21. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization.
    Porjazoska A; Goracinova K; Mladenovska K; Glavas M; Simonovska M; Janjević EI; Cvetkovska M
    Acta Pharm; 2004 Sep; 54(3):215-29. PubMed ID: 15610618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term release of clodronate from biodegradable microspheres.
    Perugini P; Genta I; Conti B; Modena T; Pavanetto F
    AAPS PharmSciTech; 2001 Jul; 2(3):E10. PubMed ID: 14727869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
    Krishnamachari Y; Madan P; Lin S
    Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
    Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
    Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L
    J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The encapsulation of a model protein in poly (D, L lactide-co-glycolide) microparticles of various sizes: an evaluation of process reproducibility.
    McGee JP; Singh M; Li XM; Qiu H; O'Hagan DT
    J Microencapsul; 1997; 14(2):197-210. PubMed ID: 9132471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method.
    Coombes AG; Yeh MK; Lavelle EC; Davis SS
    J Control Release; 1998 Mar; 52(3):311-20. PubMed ID: 9743451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres].
    Blanco-Prieto MJ; Fattal E; Puisieux F; Couvreur P
    Ann Pharm Fr; 1998; 56(6):256-63. PubMed ID: 9872012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.
    Dong WY; Körber M; López Esguerra V; Bodmeier R
    J Control Release; 2006 Oct; 115(2):158-67. PubMed ID: 16963145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability and release characteristics of poly(D,L-lactide-co-glycolide) encapsulated CaPi-DNA coprecipitation.
    Li Y; Ogris M; Pelisek J; Röedl W
    Int J Pharm; 2004 Jan; 269(1):61-70. PubMed ID: 14698577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides.
    Sophocleous AM; Desai KG; Mazzara JM; Tong L; Cheng JX; Olsen KF; Schwendeman SP
    J Control Release; 2013 Dec; 172(3):662-70. PubMed ID: 24021356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of topical cidofovir penetration using microparticles.
    Santoyo S; Ga de Jalón E; Ygartua P; Renedo MJ; Blanco-Príeto MJ
    Int J Pharm; 2002 Aug; 242(1-2):107-13. PubMed ID: 12176232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.
    Sharifi F; Otte A; Yoon G; Park K
    J Control Release; 2020 Sep; 325():347-358. PubMed ID: 32645336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of microparticles for controlled release of resveratrol to adipose tissue and the impact of drug loading on particle morphology and drug release.
    Isely C; Hendley MA; Murphy KP; Kader S; Annamalai P; Jabbari E; Gower RM
    Int J Pharm; 2019 Sep; 568():118469. PubMed ID: 31265884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.
    Igartua M; Hernández RM; Esquisabel A; Gascon AR; Calvo MB; Pedraz JL
    J Microencapsul; 1997; 14(3):349-56. PubMed ID: 9147284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.